Trending...
- Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
- Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
- Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
TEL AVIV, Israel - Michimich -- VALFIX Medical Inc. announces today that it has secured its fourth grant from the Israel Innovation Authority. This is the fourth consecutive year that VALFIX Medical is receiving an R&D grant from the Israel Innovation Authority and is the largest amount the company has ever been granted.
This grant is complementary to the company's current Series A investment round. "This grant is a part of our efforts to raise funds for our current series A investment round and secures a significant capital of this round," states Eli Bar, VALFIX Medical CEO. "We know that receiving this grant for the fourth consecutive time sets us apart and validates our ongoing success and accomplishments in our development. We look forward to closing this round and continuing to advance our technology."
This Series A investment round will fund team expansion, production scale up, V&V testing, and first in human clinical study.
More on Michimich.com
VALFIX Medical has received a total of more than 9 million NIS (2.6 million USD) in grants from the Israel Innovation Authority since 2017. Approval for grants from the Israel Innovation Authority requires due diligence and an extensive review of the company's ongoing achievements, progression and execution, assets, and plans.
About VALFIX Medical:
VALFIX Medical has designed an innovative transcatheter system to convert open heart valve surgery to a transcatheter procedure bringing new hope to FMR patients suffering from heart failure.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com
About the Israel Innovation Authority
The Israel Innovation Authority is an independent publicly funded agency, created to provide a variety of practical tools and funding platforms for early-stage entrepreneurs. https://innovationisrael.org.il/en/
This grant is complementary to the company's current Series A investment round. "This grant is a part of our efforts to raise funds for our current series A investment round and secures a significant capital of this round," states Eli Bar, VALFIX Medical CEO. "We know that receiving this grant for the fourth consecutive time sets us apart and validates our ongoing success and accomplishments in our development. We look forward to closing this round and continuing to advance our technology."
This Series A investment round will fund team expansion, production scale up, V&V testing, and first in human clinical study.
More on Michimich.com
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- Roofman USA Encourages Ann Arbor Homeowners to Plan Ahead for Roof Replacements in 2026
- Wilderness Construction Highlights Design Details That Transform Bathrooms into Spa Sanctuaries
- Japanese Martial Arts Center Helps Students Find Strength and Balance Through Structured Training
- CMR Mechanical Shares Expert Tips to Prevent Furnace Breakdowns This Winter
VALFIX Medical has received a total of more than 9 million NIS (2.6 million USD) in grants from the Israel Innovation Authority since 2017. Approval for grants from the Israel Innovation Authority requires due diligence and an extensive review of the company's ongoing achievements, progression and execution, assets, and plans.
About VALFIX Medical:
VALFIX Medical has designed an innovative transcatheter system to convert open heart valve surgery to a transcatheter procedure bringing new hope to FMR patients suffering from heart failure.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com
About the Israel Innovation Authority
The Israel Innovation Authority is an independent publicly funded agency, created to provide a variety of practical tools and funding platforms for early-stage entrepreneurs. https://innovationisrael.org.il/en/
Source: VALFIX Medical
Filed Under: Health
0 Comments
Latest on Michimich.com
- Ohana Growth Partners Expands Into Wisconsin With Its First Planet Fitness Club
- Holiday Decorations Most Likely to Cause Injuries
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
- BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
- UK Financial Ltd Announces It's Official Corporate Headquarters In The United Kingdom
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
- FreeTo.Chat - The bold, Anonymous Confession Platform, ushers in a new era of tension relief
- Female Founders Institute Announces Special Performance by Caitlin McGrath at the 2026 Charity Gala
- Hyatt House Fresno Celebrates Grand Opening, Introducing the First Hyatt House in Fresno, California
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- Novi Glass Company Says Why Custom Mirrors are Better
- Michigan Debt Collection Agency Helps Creditors Start the New Year Fresh!
- Ann Arbor Chiropractor Uses ESWT to Treat Elbow Pain
- Ann Arbor Computer Service Shares the Spirit of Giving!
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
- Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
- London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
- myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test

